Loading…

Ginkgolide B ameliorates NLRP3 inflammasome activation after hypoxic-ischemic brain injury in the neonatal male rat

•GB alleviated hypoxic-ischemic brain injury in the neonatal male rat.•GB treatment dramatically suppressed microglia activation and NLRP3 expression.•GB pretreatment significantly inhibited signal 1 and signal 2 of NLRP3 inflammasome activation. Perinatal hypoxic-ischemic (HI) insult is an importan...

Full description

Saved in:
Bibliographic Details
Published in:International journal of developmental neuroscience 2018-10, Vol.69 (1), p.106-111
Main Authors: Chen, Aiming, Xu, Yin, Yuan, Jun
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•GB alleviated hypoxic-ischemic brain injury in the neonatal male rat.•GB treatment dramatically suppressed microglia activation and NLRP3 expression.•GB pretreatment significantly inhibited signal 1 and signal 2 of NLRP3 inflammasome activation. Perinatal hypoxic-ischemic (HI) insult is an important cause of brain injury in neonates. The development of novel treatment strategies for neonates with HI brain injury is urgently needed. Ginkgolide B (GB) is a main component of Ginkgo biloba extracts with a long history of use in traditional Chinese medicine. However, it is unknown whether GB could play a protective role in hypoxic stress in immature animals. Using neonatal hypoxic-ischemic (HI) brain injury model of rat pups, neurological score, infarct size, and brain edema were evaluated after HI injury. The activation of microglia and the production of IL-1β and IL-18 were detected by immunohistochemistry and ELISA, respectively. A priming signal (NF-κB P65) and an activation signal (Caspase-1) of NLRP3 inflammasome activation were detected by western blot analyses. GB administrated 30 min prior to ischemia induction can improve neurological disorder, reduce infarct volume and alleviate cerebral edema. Compared with the HI groups, GB inhibited the activation of microglia and decreased the production of IL-1β and IL-18 in neocortex. Furthermore, GB reduced NLRP3 expression mainly in microglia, and significantly inhibited the expression of Caspase-1 and the nuclear translocation of NF-κB P65, preventing NLRP3 inflammasome activation. GB ameliorates hypoxic-ischemic brain injury in the neonatal male rat via inhibiting NLRP3 inflammasome activation.
ISSN:0736-5748
1873-474X
DOI:10.1016/j.ijdevneu.2018.07.004